Immune checkpoints in antitumor response: a potential antitumor immunotherapy
PD-1/PD-L1 checkpoint. The action mechanism begins when T cells are activated upon recognition of the antigen presented in HLA-I, triggering a signaling cascade and the release of cytokines that activate their proliferation. (A) In a normal microenvironment, after T cell activation and proliferation, immune checkpoint proteins, such as PD-1 and its ligand PDL-1, are expressed that prevent their excessive activation. (B) In a tumor microenvironment, the expression of immune checkpoints favors escape from immunosurveillance. Once T cells recognize the tumor antigen presented in HLA-I, they are activated and produce IFN-γ that binds to the IFN-γ receptor, inducing PD-L1 overexpression in tumor cells. PD-L1 binds to PD-1, which is overregulated in T cells, and thus inhibits the immune response. (C) PD-L1 can interact with CD80/CD86 on the antigen-presenting cell (APC) and disrupt PD-L1/PD-1 binding. It has been documented that CD80/CD86 are not only expressed on APCs but also on T cells, suggesting that it may be another pathway in T cells that may serve to downregulate responses and prevent T cell signals. (D) Anti-PD-1 antibody or anti-PD-L1 blocks the interaction of PD-1 and PD-L1 and suppresses the inhibition of CD8+ T cells, thereby enhancing antitumor activity.
Publication
The role of immune checkpoints in antitumor response: a potential antitumor immunotherapy. (2023) Lidy Vannessa Mejía-Guarnizo, et al. Front Immunol. 2023;14:1298571. Figure: F3.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | CD8 | CD8 | ncbigene_synonym | CD8A | 925 |
| Homo sapiens | Primates | CD8 | CD8 | famplex_relations | CD8B | 926 |
| Homo sapiens | Primates | PD-L1 | PD-L1 | ncbigene_synonym | CD274 | 29126 |
| Homo sapiens | Primates | PD-1 | PD-1 | ncbigene_synonym | PDCD1 | 5133 |
| Homo sapiens | Primates | PD-1 | PD-1 | ncbigene_synonym | RPL17 | 6139 |
| Homo sapiens | Primates | PD-1 | PD-1 | ncbigene_synonym | RPL17-C18orf32 | 100526842 |
| Homo sapiens | Primates | TCR | TCR | ncbigene_synonym | TRBV20OR9-2 | 6962 |
| Homo sapiens | Primates | TCR | TCR | famplex_relations | TRA | 6955 |
| Homo sapiens | Primates | TCR | TCR | famplex_relations | TRB | 6957 |
| Homo sapiens | Primates | TCR | TCR | famplex_relations | TRD | 6964 |
| Homo sapiens | Primates | TCR | TCR | famplex_relations | TRG | 6965 |
| Homo sapiens | Primates | CD28 | CD28 | ncbigene_symbol | CD28 | 940 |
| Homo sapiens | Primates | CD80 | CD80 | ncbigene_symbol | CD80 | 941 |
| Homo sapiens | Primates | CD86 | CD86 | ncbigene_symbol | CD86 | 942 |
| Homo sapiens | Primates | JAK1/2 | JAK2 | ncbigene_symbol | JAK2 | 3717 |
| Homo sapiens | Primates | JAK1/2 | JAK1 | ncbigene_symbol | JAK1 | 3716 |
| Homo sapiens | Primates | JAK | JAK | famplex_relations | JAK3 | 3718 |
| Homo sapiens | Primates | JAK | JAK | famplex_relations | TYK2 | 7297 |
| Homo sapiens | Primates | STAT1 | STAT1 | ncbigene_symbol | STAT1 | 6772 |
| Homo sapiens | Primates | STAT | STAT | ncbigene_synonym | SOAT1 | 6646 |
| Homo sapiens | Primates | STAT | STAT | famplex_relations | STAT2 | 6773 |
| Homo sapiens | Primates | STAT | STAT | famplex_relations | STAT3 | 6774 |
| Homo sapiens | Primates | STAT | STAT | famplex_relations | STAT4 | 6775 |
| Homo sapiens | Primates | STAT | STAT | famplex_relations | STAT6 | 6778 |
| Homo sapiens | Primates | STAT | STAT | famplex_relations | STAT5A | 6776 |
| Homo sapiens | Primates | STAT | STAT | famplex_relations | STAT5B | 6777 |
| Homo sapiens | Primates | APC | APC | ncbigene_symbol | APC | 324 |
| Homo sapiens | Primates | APC | APC | ncbigene_synonym | PROC | 5624 |
| Homo sapiens | Primates | IRF1 | IRF1 | ncbigene_symbol | IRF1 | 3659 |
| Word | Match | MeSH | Name | ChEBI |
|---|
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|